The U.S. Food and Drug Administration has accepted Novo Nordisk's marketing application for an oral version of its ...

Novo Nordisk ( NVO 0.33%) stock jumped 3.1% at the open Thursday morning before drifting back. As of 10:54 a.m. ET, it was ...

Novo Nordisk said on Tuesday it was working with telehealth firms Hims & Hers , Ro and LifeMD to sell Wegovy, as it looks to ...

Novo Nordisk , the producer of Ozempic, Wegovy and other medications, will invest 6.4 billion reais ($1.09 billion) in Brazil ...

Novo Nordisk has launched its hugely popular weight-loss drug Wegovy in Thailand, an executive of the Danish drugmaker's ...

Novo Nordisk said on Tuesday it was partnering with telehealth firms Hims & Hers, Ro and LifeMD to sell branded versions of ...

according to a Reuters survey. April 14, 2025 Novo Nordisk warns consumers about counterfeit versions of Ozempic in US Danish drugmaker Novo Nordisk said on Monday several hundred counterfeit ...

Novo Nordisk (NVO) has launched its weight-loss drug Wegovy in Thailand, Reuters reported on Monday, citing an executive of ...

Novo Nordisk to sell Wegovy through telehealth ... promised corporate and personal tax cuts to Jan. 1, 2025, she told Reuters. Healthcare & Pharmaceuticalscategory· December 19, 2024 US FDA ...

On Thursday, Reuters reported weak U.S. prescription data is contributing to investor concerns that Novo Nordisk is no longer ...

Novo Nordisk (NYSE: NVO) stock jumped 3.1% at the open Thursday morning before drifting back. As of 10:54 a.m. ET, it was still up by about 1.2%. The stock is benefiting from an exclusive Reuters ...